Abstract
Purpose:To assess the safety and efficacy of biweekly (every 2 weeks) intravitreal aflibercept injections (IAI) 2 mg in eyes with refractory neovascul......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
